Loading company…
Spotlight Medical develops AI-powered prognosis tests to help physicians select cancer treatments.
Spotlight Medical develops AI-based prognosis tests that analyze patient data to help physicians choose personalized cancer treatment strategies. Founded in 2024 by Grégoire Gessain, Marvin Lerousseau, and Sylvain Berlemont, the company is based in Paris, France, and is at the Seed stage. In July 2024, it raised EUR 6.2 million co-led by Kurma Partners and Heal Capital to prepare its first test for clinical use.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in